Amyris & Genome Compiler Partner to Commercialize DNA Construction Software Services for the Pharma and Biotech Industries

Combination of Amyris’s DNA construction capabilities and Genome Compiler’s computer-aided DNA design software aims to accelerate development of therapeutics   EMERYVILLE and LOS ALTOS, Calif., March 3, 2015 — Amyris, Inc. (Nasdaq:AMRS), an industrial bioscience company, and Genome Compiler Corp., a synthetic biology platform company, have entered into a collaboration agreement to integrate Amyris’s automated lab services with…

Cloning Like a Wizard with Genome Compiler

Construct your vector by restriction ligation or Gibson Assembly in just 4 easy steps! We've heard your requests, and have created a cloning wizard to put a little magic in your design! Benefits Error free - save time by eliminating errors from your design Auto generate your cloned product - smart filtering of compatible restriction sites Easily see and verify your…

Cellectis Plant Sciences and the Two Blades Allow for Precise Genome Editing in plants by Nucleases

Cellectis plant sciences and the Two Blades Foundations (2Blades), two organizations with a common mission of developing techniques to improve the quality of crops, have announced a cross-license agreement of their TAL nuclease technologies. TALEN Technology™ (Cellectis plant sciences) and TAL code technology (2Blades) allow for precise genome editing in plants by utilizing nucleases. Nucleases…

Bio-Incubator for Synthetic Biology Companies Launched at Indian Insititute of Technology-Madras

Synthetic biology is ready to start flapping its wings in southern India. The Indian Institute of Technology Madras (IIT-M) located in Chennai has launched a bio-incubator assisted with 120 Million USD of funding from the Biotechnology Industry Research Assistance Council (BIRAC), a body of the central government. In an effort to promote entrepreneurship in India, the central government has…

Genome Compiler - The Platform for Synthetic Biology Tools Welcomes DNA2.0 as a Premium Synthesis Partner

Los Altos, CA and Menlo Park, CA (November 14, 2014). Genome Compiler Corp., a Los Altos based synthetic biology software company entered into a collaborative agreement with DNA2.0, a leading provider of gene synthesis and bioengineering solutions located in Menlo Park, CA. Genome Compiler will be integrating DNA2.0’s gene synthesis services into their design platform,…

The Gates Foundation Helps Launch Affinivax - A Vaccine Development Firm

A new vaccine development firm, Affinivax, was recently initiated thanks to funding from the Bill & Melinda Gates Foundation and may receive future funding based on its performance. Affinivax plans on continuing to develop its Multiple Antigen Presenting System (MAPS) and other vaccine development projects with the initial four million dollar investment. The company will…

De Novo DNA is Joining Genome Compiler’s Suite of Advanced Tools to create Comprehensive Synthetic Biology Solutions

Los Altos, CA and City State, Pennsylvania (September 3, 2014). Genome Compiler Corp., a Los Altos based synthetic biology software company entered into a collaborative agreement with De Novo DNA, a biophysics based genetic software company located in State College, PA. Genome Compiler will be leveraging De Novo DNA’s expertise to further enrich their platform…

General Mills Debate over GMOs

    General Mills Inc. struck down a proposal to ban GMOs (Genetically Modified Organisms) as ingredients from all their brands last week at their annual shareholder meeting. A resounding 98 percent of shareholders voted against a companywide ban. The definitive decision comes as somewhat of a surprise because of the company’s recent removal of…

Igenbio and Genome Compiler Corp. Enter into a Collaborative Agreement to Offer Synthetic Biology Solutions

Chicago, Illinois and Los Altos, CA (Aug 3, 2014). Igenbio. Inc a, Chicago based genome analysis company announced today they entered into a collaborative agreement with Genome Compiler Corp., a Los Altos based synthetic biology software company. Igenbio and Genome Compiler are partnering to create comprehensive synthetic biology solutions. Igenbio Japan will be promoting and…

Leading Scientists Address Congress on Future of Synthetic Biology

Dr. Karmella Haynes, an assistant professor from Arizona State University, was among a small group of scientists who addressed a recent Congressional hearing about the emerging field of Synthetic Biology. In the Haynes Lab at the ASU School of Biological and Health Systems Engineering, Dr. Haynes is currently involved in synthetic biology research in the hopes of…

Debugging Complex Synthetic Biology Work has Never Been Easier

Simplifying Synthetic Biology: The Compilation Design Rules Engine Genome Compiler’s new Compilation Design Rules Engine ensures users that their synthetic biology projects follow nature’s engineering constraints as well specific rules from the industry’s most prominent synthesizers. Also look forward for future releases to establish your own design constraints as well. Debugging complex synthetic biology work has…

The Next Step in Synthetic Biology? New Artificial Nuelotides can Change the Basics

This week, the synthetic biology community is excited to add two new materials to its genetic toolbox. Researchers at The Scripps Research Institute of La Jolla, California have announced the successful synthesis of two entirely synthetic nucleobases with the ability of incorporating the new proteins into the DNA of E. Coli bacteria. These breakthrough findings…

What 80 Biologists Working on the First Synthetic Yeast Chromosome Wish they had

With the most recent triumph of developing the world’s first completely synthetic eukaryotic chromosome under the leadership of Dr. Jef Boeke’s Johns Hopkins lab it is clear that ambitions within the field of Synthetic Biology are growing larger every day. With these incredible undertakings come larger sequences, and with these larger sequences come larger teams…

Genome Compiler In the news!

Venture Beat published an article discussing the acceleration of data, technology, and human capability. The article examined the future of bio-tech and GC was recognized as a leader in the field. The re-emergence of BioTech, or BioTech 2.0, is a great example of innovation in automating procedures on top of newly procured datasets. Companies like Transcriptic are…